.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chubb
US Department of Justice
Accenture
US Army
Julphar
McKesson
Medtronic
Chinese Patent Office
Farmers Insurance

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086231

« Back to Dashboard
NDA 086231 describes BUTALBITAL, ASPIRIN AND CAFFEINE, which is a drug marketed by Actavis Elizabeth, Watson Labs, Ivax Pharms, Halsey, Puracap Pharm, Nostrum Labs Inc, Hikma Intl Pharms, Quantum Pharmics, PII, and Sandoz, and is included in eleven NDAs. It is available from nine suppliers. Additional details are available on the BUTALBITAL, ASPIRIN AND CAFFEINE profile page.

The generic ingredient in BUTALBITAL, ASPIRIN AND CAFFEINE is aspirin; butalbital; caffeine. There are twenty-one drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine profile page.

Summary for 086231

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 086231

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUTALBITAL, ASPIRIN AND CAFFEINE
aspirin; butalbital; caffeine
CAPSULE;ORAL 086231 ANDA Rebel Distributors Corp 21695-139 21695-139-60 60 CAPSULE in 1 BOTTLE (21695-139-60)

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength325MG;50MG;40MG
Approval Date:Feb 12, 1985TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Cerilliant
Harvard Business School
Covington
Mallinckrodt
QuintilesIMS
Queensland Health
Citi
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot